DYN
Dyne Therapeutics Inc
16.60$
+1.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 82.0% | 78.4% | 93.5% | 95.9% | 95.8% | 95.4% | 95.6% | 95.7% | 93.0% | 94.9% | 94.5% | 94.4% | |
| 63.5% | 73.7% | 52.1% | 73.6% | 69.2% | 63.0% | 65.5% | 66.5% | 66.2% | 75.3% | 69.7% | 68.0% | |
| 76.9% | 74.6% | 86.8% | 94.3% | 94.1% | 92.9% | 94.0% | 93.8% | 91.3% | 93.6% | 90.0% | 90.4% | |
| 25.9% | 44.7% | 8.5% | 6.1% | 8.2% | 8.9% | 7.2% | 21.6% | 20.2% | 18.1% | 19.9% | 29.4% | |
| 14.5% | 31.0% | 4.3% | 3.6% | 5.6% | 6.1% | 4.7% | 5.7% | 6.9% | 4.3% | 4.7% | 7.8% | |
| 2.3% | 2.9% | 0.9% | 0.6% | 0.6% | 0.7% | 0.7% | 0.7% | 0.6% | 0.4% | 0.5% | 0.5% | |
| 1.7% | 13.9% | 1.4% | 0.2% | 0.8% | 0.9% | 1.0% | 1.9% | 1.4% | 0.7% | 1.0% | 1.2% | |
| – | – | – | – | – | – | – | 13.6% | 11.4% | 12.5% | 13.8% | 20.1% | |
| 74.1% | 55.3% | 91.5% | 93.9% | 91.8% | 91.1% | 92.8% | 78.4% | 79.8% | 81.9% | 80.1% | 70.6% | |
| -275.7% | -383.1% | -133.7% | -92.4% | -111.9% | -137.4% | -147.7% | -161.3% | -148.1% | -117.6% | -140.5% | -170.6% | |
| 29.8% | 37.2% | 15.5% | 11.2% | 13.1% | 14.8% | 15.2% | 15.6% | 16.4% | 10.8% | 15.3% | 16.6% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.